BRIEF-TME Pharma Says Net Proceeds To Extend Financial Visibility Into June 2025

Reuters12-04

Dec 4 (Reuters) - TME Pharma NV :

* TME PHARMA ANNOUNCES CORPORATE STRATEGY UPDATE AND UPCOMING €2.6 MILLION GUARANTEED FINANCING WITH INTENTION TO LAUNCH PUBLIC OFFER OPEN ONLY TO SHAREHOLDERS TO ENABLE COMPLETION OF TRANSACTIONS AROUND NOX-A12 AND NOX-E36 BY JUNE 2025

* TME PHARMA NV - NET PROCEEDS TO EXTEND FINANCIAL VISIBILITY INTO JUNE 2025

* TME PHARMA NV - TO OPERATE ON REDUCED COST BASE IF NEEDED

* TME PHARMA NV - PUBLIC OFFER TO LAUNCH DECEMBER 12, 2024, PRIORITY FOR SHAREHOLDERS

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2488380130?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-04 15:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2488380130","market":"us","top_or_hot":-1,"title":"BRIEF-TME Pharma Says Net Proceeds To Extend Financial Visibility Into June 2025","media":"Reuters","content":"<html><body><p>Dec 4 (Reuters) - TME Pharma NV   :</p><p>   * TME PHARMA ANNOUNCES CORPORATE STRATEGY UPDATE AND UPCOMING €2.6 MILLION GUARANTEED FINANCING WITH INTENTION TO LAUNCH PUBLIC OFFER OPEN ONLY TO SHAREHOLDERS TO ENABLE COMPLETION OF TRANSACTIONS AROUND NOX-A12 AND NOX-E36 BY JUNE 2025</p><p>   * TME PHARMA NV - NET PROCEEDS TO EXTEND FINANCIAL VISIBILITY INTO JUNE 2025</p><p>   * TME PHARMA NV - TO OPERATE ON REDUCED COST BASE IF NEEDED</p><p>   * TME PHARMA NV - PUBLIC OFFER TO LAUNCH DECEMBER 12, 2024, PRIORITY FOR SHAREHOLDERS</p><p>Source text:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-TME Pharma Says Net Proceeds To Extend Financial Visibility Into June 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-TME Pharma Says Net Proceeds To Extend Financial Visibility Into June 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-04 15:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dec 4 (Reuters) - TME Pharma NV   :   * TME PHARMA ANNOUNCES CORPORATE STRATEGY UPDATE AND UPCOMING €2.6 MILLION GUARANTEED FINANCING WITH INTENTION TO LAUNCH PUBLIC OFFER OPEN ONLY TO SHAREHOLDERS TO...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4535","symbol_name":"淡马锡持仓","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2488380130","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488380130","pubTimestamp":1733297172,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Dec 4  - TME Pharma NV   :   * TME PHARMA ANNOUNCES CORPORATE STRATEGY UPDATE AND UPCOMING 2.6 MILLION GUARANTEED FINANCING WITH INTENTION TO LAUNCH PUBLIC OFFER OPEN ONLY TO SHAREHOLDERS TO ENABLE COMPLETION OF TRANSACTIONS AROUND NOX-A12 AND NOX-E36 BY JUNE 2025   * TME PHARMA NV - NET PROCEEDS TO EXTEND FINANCIAL VISIBILITY INTO JUNE 2025   * TME PHARMA NV - TO OPERATE ON REDUCED COST BASE IF NEEDED   * TME PHARMA NV - PUBLIC OFFER TO LAUNCH DECEMBER 12, 2024, PRIORITY FOR SHAREHOLDERSSource text:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4535":"淡马锡持仓","01698":"腾讯音乐-SW","IE00BYQNZ168.SGD":"PINEBRIDGE ASIA EX JAPAN SMALL CAP EQUITY \"A5CP\" (SGD) ACC","SG9999011746.SGD":"PINEBRIDGE INTERNATIONAL FUNDS - ACORNS OF ASIA BA (SGD) ACC","BK4526":"热门中概股","BK4552":"Archegos爆仓风波概念","LU2039709279.SGD":"MANULIFE GF DRAGON GROWTH \"AA\" (SGDHDG) INC","IE00BYTNYN87.SGD":"PINEBRIDGE ASIA EX JAPAN SMALL CAP EQUITY \"A5\" (SGD) ACC","IE00B12V2V27.USD":"柏瑞亚洲小盘股A(除日本)","BK4548":"巴美列捷福持仓","BK4563":"昨日强势股","BK4565":"NFT概念","LU0359201612.USD":"贝莱德中国基金A2","LU0359202008.SGD":"Blackrock China Fund A2 SGD-H","LU1023057109.AUD":"BGF CHINA \"A2\" (AUDHDG) ACC","BK4531":"中概回港概念","BK4571":"数字音乐概念","BK4108":"电影和娱乐","TME":"腾讯音乐","BK4509":"腾讯概念"},"translate_title":"简介-TME Pharma表示净收益将延长至2025年6月","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TME":1,"01698":0.6},"content_text":"Dec 4 (Reuters) - TME Pharma NV   :   * TME PHARMA ANNOUNCES CORPORATE STRATEGY UPDATE AND UPCOMING €2.6 MILLION GUARANTEED FINANCING WITH INTENTION TO LAUNCH PUBLIC OFFER OPEN ONLY TO SHAREHOLDERS TO ENABLE COMPLETION OF TRANSACTIONS AROUND NOX-A12 AND NOX-E36 BY JUNE 2025   * TME PHARMA NV - NET PROCEEDS TO EXTEND FINANCIAL VISIBILITY INTO JUNE 2025   * TME PHARMA NV - TO OPERATE ON REDUCED COST BASE IF NEEDED   * TME PHARMA NV - PUBLIC OFFER TO LAUNCH DECEMBER 12, 2024, PRIORITY FOR SHAREHOLDERSSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2488380130"}